subject: DRUGBANK:DB17463

object_name: Solid Neoplasm


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Refractory Lymphoma

tested_intervention: unsure


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:3S9RX35S5X

subject_name: Fimepinostat


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:8426

subject_name: Probenecid

object_name: Craving

tested_intervention: yes


subject: CHEBI:8426

object_name: alcohol consumption (history)


subject: CHEBI:8426

object_name: alcohol dependence


subject: CHEBI:64816

object_name: primary effusion lymphoma


subject: CHEBI:72690

subject_name: Pomalidomide


subject: CHEBI:143658


subject: PUBCHEM.COMPOUND:167518234

subject_name: Atilotrelvir


subject: DRUGBANK:DB19439


subject: UNII:PX665RAA3H

subject_name: Ensitrelvir


subject: UMLS:C0520150

subject_name: MUROMONAB-CD3, PARENTERAL, 5 MG ADMINISTERED


subject: UMLS:C3542957

subject_name: Monoclonal antibodies, antineoplastic


subject: UMLS:C0003250

subject_name: Monoclonal Antibodies


subject: UNII:L1F3R18W77

subject_name: Asciminib

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UMLS:C2604734

subject_name: briakinumab

object_name: psoriasis


subject: PUBCHEM.COMPOUND:127236

object_name: EXCESS LMW-DNA


subject: PR:000001406

subject_name: tumor necrosis factor receptor superfamily member 17


subject: UniProtKB:P53767

subject_name: VGFR1_RAT Vascular endothelial growth factor receptor 1 (sprot)

object_name: colorectal cancer


subject: UniProtKB:P53767

object_name: colorectal carcinoma


subject: UniProtKB:P53767

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UniProtKB:P53767

object_name: rectal carcinoma


subject: UniProtKB:P53767

object_name: rectal cancer


subject: UniProtKB:P53767

object_name: Childhood Rectal Carcinoma


subject: UniProtKB:P53767

object_name: colon carcinoma


subject: UniProtKB:P53767

object_name: colon cancer


subject: PR:000007563

subject_name: vascular endothelial growth factor receptor 1


subject: PR:000007563


subject: PR:000007563


subject: PR:000007563


subject: PR:000007563


subject: PR:000007563


subject: PR:000007563


subject: PR:000007563


subject: PR:000002112

subject_name: vascular endothelial growth factor receptor 2


subject: PR:000002112


subject: PR:000002112


subject: PR:000002112


subject: PR:000002112


subject: PR:000002112


subject: PR:000002112


subject: PR:000002112


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: Nutritional status


subject: CHEBI:17061

object_name: short bowel syndrome


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: CHEBI:49956

subject_name: Xenon

object_name: Severe asthma


subject: CHEBI:76003

subject_name: afatinib dimaleate

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:76003

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:76003

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:76003

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:91400

subject_name: Afatinib


subject: CHEBI:91400


subject: CHEBI:91400


subject: CHEBI:91400


subject: CHEBI:109549

subject_name: Ramelteon

object_name: substance abuse


subject: CHEBI:9674

subject_name: Triazolam


subject: UMLS:C3273725

object_name: oropharyngeal carcinoma


subject: UMLS:C3273725

object_name: oropharynx cancer


subject: UMLS:C3273725

object_name: cervical cancer


subject: UMLS:C3273725

object_name: cervical carcinoma


subject: UMLS:C3273725

object_name: anus cancer


subject: UMLS:C3273725

object_name: anal carcinoma


subject: UMLS:C3827090

subject_name: Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101


subject: UMLS:C3827090


subject: UMLS:C3827090


subject: UMLS:C3827090


subject: UMLS:C3827090


subject: UMLS:C3827090


subject: UMLS:C5203017

subject_name: G-Series Nerve Agent GB

object_name: cytomegalovirus infection


subject: CHEBI:16867

subject_name: D-Methionine


subject: CHEBI:109549

object_name: chronic obstructive pulmonary disease


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Polycystic ovary syndrome of bilateral ovaries


subject: PUBCHEM.COMPOUND:66743180

subject_name: Telotristat

object_name: neuroendocrine neoplasm


subject: UMLS:C3884837

subject_name: telotristat


subject: CHEBI:41423

subject_name: Celecoxib

object_name: uterine fibroid


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:9605

subject_name: Tirofiban

object_name: Thromboembolism


subject: UNII:MF497J489P

subject_name: MOSAPRIDE CITRATE

object_name: Stomach cancer


subject: UNII:MF497J489P

object_name: gastric cancer


subject: UMLS:C0245956

subject_name: Mosapride citrate


subject: UMLS:C0245956


subject: CHEBI:167204

subject_name: Mosapride


subject: CHEBI:167204


subject: UMLS:C2604734

subject_name: briakinumab

object_name: multiple sclerosis


subject: CHEBI:3638

subject_name: Chloroquine

object_name: G6PD deficiency


subject: CHEBI:3638

object_name: class V glucose-6-phosphate dehydrogenase deficiency


subject: CHEBI:8405

subject_name: Primaquine


subject: CHEBI:8405


subject: CHEBI:31781

subject_name: Lopinavir

object_name: Hodgkin Disease


subject: CHEBI:31781

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:31781

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:31781

object_name: Stage I Adult Hodgkin Lymphoma


subject: CHEBI:31781

object_name: Stage II Adult Hodgkin Lymphoma


subject: CHEBI:31781

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:31781

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:45409


subject: CHEBI:45409


subject: CHEBI:45409


subject: CHEBI:45409


subject: CHEBI:45409


subject: CHEBI:45409


subject: UNII:9G6U5L461Q

subject_name: Icotinib

object_name: Activating EGFR Gene Mutation


subject: CHEBI:174348

object_name: Uterine hemorrhage


subject: CHEBI:174348

object_name: Uterine Hemorrhage, CTCAE


subject: CHEBI:6717

subject_name: Mefenamic acid


subject: CHEBI:6717


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: Steroid-Refractory Pneumonitis


subject: UNII:B72HH48FLU

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:B72HH48FLU

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:B72HH48FLU

object_name: Malignant Solid Neoplasm


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous


subject: UMLS:C0085297


subject: UMLS:C0085297


subject: UMLS:C0085297


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:31498

subject_name: Simethicone

object_name: ileus


subject: CHEBI:31498

object_name: Ileus, CTCAE


subject: CHEBI:31498

object_name: Postoperative ileus


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:3732

object_name: DS Stage I Plasma Cell Myeloma


subject: CHEBI:3732

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:47499

subject_name: Imipramine

object_name: Heartburn


subject: CHEBI:47499

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: CHEBI:5062

subject_name: Finasteride

object_name: Sexual Dysfunction and Infertility


subject: CHEBI:5132

subject_name: Flutamide


subject: CHEBI:3242

subject_name: butorphanol

object_name: respiratory failure


subject: CHEBI:3242

object_name: bronchopulmonary dysplasia


subject: CHEBI:3242

object_name: Respiratory insufficiency


subject: CHEBI:119915

subject_name: Fentanyl


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Human Papillomavirus Positive


subject: UNII:28X28X9OKV

object_name: Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UNII:28X28X9OKV

object_name: Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UNII:28X28X9OKV

object_name: Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UNII:28X28X9OKV

object_name: p16-Positive Neoplastic Cells Present


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX

object_name: oropharynx squamous cell carcinoma


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX

object_name: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX

object_name: Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: PUBCHEM.COMPOUND:137357786

object_name: infectious disease


subject: PUBCHEM.COMPOUND:137357786

object_name: bacterial infectious disease


subject: UNII:5M691HL4BO

subject_name: glatiramer acetate

object_name: diabetic retinopathy


subject: UMLS:C5555652

subject_name: Engineered Red Blood Cells Expressing HPV16 E7/4-1BBL/IL-12 RTX-321

object_name: anus cancer


subject: UMLS:C5555652

object_name: anal carcinoma


subject: UMLS:C5555652

object_name: cervical cancer


subject: UMLS:C5555652

object_name: cervical carcinoma


subject: UMLS:C5555652

object_name: Neck Carcinoma


subject: UMLS:C5555652

object_name: head and neck neoplasm


subject: UMLS:C5555652

object_name: head and neck cancer


subject: CHEBI:135285

subject_name: Vildagliptin

object_name: maturity-onset diabetes of the young type 1


subject: PUBCHEM.COMPOUND:76641559

subject_name: Dorzagliatin

object_name: glucose intolerance


subject: PUBCHEM.COMPOUND:76641559

object_name: Glucose Intolerance, CTCAE


subject: CHEBI:174690

subject_name: Clenbuterol

object_name: facioscapulohumeral muscular dystrophy


subject: CHEBI:174690

object_name: facioscapulohumeral muscular dystrophy 1


subject: PUBCHEM.COMPOUND:23725028

subject_name: Stanate (TN)

object_name: Prolonged neonatal jaundice


subject: CHEMBL.COMPOUND:CHEMBL4297207

subject_name: STANNSOPORFIN


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: pharyngitis


subject: CHEBI:3614

object_name: Pharyngitis, CTCAE


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: UNII:4N9P6CC1DX

subject_name: Echinacea


subject: UNII:4N9P6CC1DX


subject: UMLS:C5445960

subject_name: Echinacea antigen


subject: UMLS:C5445960


subject: DRUGBANK:DB10982

subject_name: Sage


subject: DRUGBANK:DB10982


subject: DRUGBANK:DB11199

subject_name: Sage oil


subject: DRUGBANK:DB11199


subject: MESH:C030259

subject_name: Broncho-Vaxom

object_name: atopic eczema


subject: DRUGBANK:DB16533


subject: UMLS:C0718247

subject_name: Active brand of pseudoephedrine-triprolidine

object_name: Weight loss


subject: UMLS:C0718247

object_name: Weight Loss, CTCAE


subject: CHEBI:27732

subject_name: Caffeine


subject: CHEBI:27732


subject: PUBCHEM.COMPOUND:2367

subject_name: Betnesol

object_name: Hemorrhage


subject: PUBCHEM.COMPOUND:2367

object_name: post operative nausea and vomiting


subject: CHEBI:3077

subject_name: Betamethasone


subject: CHEBI:3077


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: glioblastoma


subject: CHEBI:6067

object_name: Brain Stem Glioblastoma


subject: CHEBI:6067

object_name: glioma susceptibility 1


subject: CHEBI:74947

subject_name: Thalidomide


subject: CHEBI:74947


subject: CHEBI:74947


subject: PUBCHEM.COMPOUND:66964417

subject_name: LACTULOSE

object_name: Chronic liver disease


subject: UNII:9U7D5QH5AE


subject: UNII:08AN7WA2G0

subject_name: TRIPTORELIN PAMOATE

object_name: metastatic prostate carcinoma


subject: UNII:08AN7WA2G0

object_name: Locally advanced prostate cancer


subject: UNII:08AN7WA2G0

object_name: Advanced prostate cancer


subject: UMLS:C1145204

subject_name: INJECTION, TRIPTORELIN PAMOATE, 3.75 MG ADMINISTERED


subject: UMLS:C1145204


subject: UMLS:C1145204


subject: CHEBI:63633

subject_name: Triptorelin


subject: CHEBI:63633


subject: CHEBI:63633


subject: UMLS:C0112708

subject_name: Trelstar


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: CHEBI:24866

subject_name: salt


subject: CHEBI:24866


subject: CHEBI:24866


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: CHEBI:26710


subject: UMLS:C5397396

subject_name: Vaccine product containing only Hepatitis A and Hepatitis B virus antigens (medicinal product)

object_name: hepatitis B


subject: UMLS:C5397396

object_name: hepatitis A


subject: UMLS:C5397396

object_name: hepatitis C


subject: UMLS:C5397396

object_name: Adherence To Medication Regime


subject: UMLS:C5397396

object_name: Substance Abuse, Intravenous


subject: MESH:C530986

subject_name: Glucerna

object_name: obesity due to melanocortin 4 receptor deficiency


subject: MESH:C530986

object_name: obesity


subject: MESH:C530986

object_name: Obesity, CTCAE


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: Pemphigoid


subject: CHEBI:28694

subject_name: Copper

object_name: motor neuron disorder


subject: CHEBI:29036

subject_name: Cupric cation


subject: CHEBI:74067

subject_name: Ile-Ile


subject: PR:000001822

subject_name: MHC class II histocompatibility antigen gamma chain


subject: PR:000007904


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: UMLS:C2095490

subject_name: corticosteroid injection

object_name: contracture


subject: UMLS:C2095490

object_name: Joint contracture


subject: UMLS:C2095490

object_name: x-ray of toe: deformity contracture


subject: UMLS:C2095490

object_name: familial Dupuytren contracture


subject: UMLS:C2095490

object_name: palmar fibromatosis


subject: UMLS:C2095490

object_name: Dupuytren's Disease


subject: UMLS:C2095490

object_name: connective and soft tissue neoplasm


subject: UMLS:C2095490

object_name: connective tissue neoplasm


subject: UMLS:C2095490

object_name: connective tissue disorder


subject: UMLS:C2095490

object_name: Neoplasms by Histologic Type


subject: UMLS:C2095490

object_name: fibroblastic neoplasm


subject: UMLS:C2095490

object_name: arthropathy


subject: UMLS:C2095490

object_name: musculoskeletal system disorder


subject: UMLS:C2095490

object_name: neoplasm


subject: UMLS:C2095490

object_name: fibroma


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Cervical radiculitis


subject: MESH:D002214

subject_name: Capsules

object_name: Prediabetes


subject: CHEBI:36704

subject_name: Imiquimod

object_name: localized scleroderma


subject: CHEBI:36704

object_name: Morphea


subject: UMLS:C5854372

subject_name: Anti-DLL3/CD3/CD137 Trispecific Antibody ALPS12

object_name: neuroendocrine carcinoma


subject: UMLS:C5854372

object_name: small cell lung carcinoma


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Childhood Rectal Carcinoma


subject: CHEBI:6931

subject_name: Midazolam

object_name: Colonic diverticula


subject: CHEBI:6931

object_name: colon carcinoma


subject: CHEBI:6931

object_name: colon cancer


subject: CHEBI:6931

object_name: rectal carcinoma


subject: CHEBI:6931

object_name: rectal cancer


subject: CHEBI:6931


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:44915


subject: MESH:C505143

subject_name: Boostrix

object_name: Premature birth


subject: MESH:C505143

object_name: premature birth (history)


subject: RXCUI:901639

subject_name: Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe


subject: RXCUI:901639


subject: CHEBI:8665

subject_name: Pyridostigmine


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Daytime Somnolence


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:8988

object_name: overall survival


subject: CHEBI:80630

subject_name: Irinotecan


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: childhood central nervous system germ cell tumor


subject: UNII:68AYS9A614

object_name: Recurrent Childhood Ependymoma


subject: UNII:68AYS9A614

object_name: Recurrent Childhood Pineoblastoma


subject: UNII:68AYS9A614

object_name: Recurrent Childhood Brain Neoplasm


subject: UNII:68AYS9A614

object_name: Recurrent Childhood Medulloblastoma


subject: UNII:68AYS9A614

object_name: Recurrent Childhood Brain Stem Glioma


subject: UNII:68AYS9A614

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: UNII:68AYS9A614

object_name: Recurrent Childhood Visual Pathway Glioma


subject: UNII:68AYS9A614

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: UNII:68AYS9A614

object_name: Recurrent Childhood Subependymal Giant Cell Astrocytoma


subject: UNII:68AYS9A614

object_name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: UNII:68AYS9A614

object_name: Childhood Atypical Teratoid/Rhabdoid Tumor


subject: UNII:68AYS9A614

object_name: pediatric infratentorial ependymoma


subject: UNII:68AYS9A614

object_name: pediatric supratentorial ependymoma


subject: UNII:68AYS9A614

object_name: Childhood Cerebral Anaplastic Astrocytoma


subject: UNII:68AYS9A614

object_name: childhood cerebral astrocytoma


subject: UNII:68AYS9A614

object_name: Childhood Grade I Meningioma


subject: UNII:68AYS9A614

object_name: Childhood Grade III Meningioma


subject: UNII:68AYS9A614

object_name: childhood spinal cord tumor


subject: UNII:68AYS9A614

object_name: Childhood Grade II Meningioma


subject: UNII:68AYS9A614

object_name: childhood oligodendroglioma


subject: UMLS:C2711999

subject_name: cediranib maleate

object_name: childhood central nervous system germ cell tumor


subject: UMLS:C2711999

object_name: Recurrent Childhood Ependymoma


subject: UMLS:C2711999

object_name: Recurrent Childhood Pineoblastoma


subject: UMLS:C2711999

object_name: Recurrent Childhood Brain Neoplasm


subject: UMLS:C2711999

object_name: Recurrent Childhood Medulloblastoma


subject: UMLS:C2711999

object_name: Recurrent Childhood Brain Stem Glioma


subject: UMLS:C2711999

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: UMLS:C2711999

object_name: Recurrent Childhood Visual Pathway Glioma


subject: UMLS:C2711999

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: UMLS:C2711999

object_name: Recurrent Childhood Subependymal Giant Cell Astrocytoma


subject: UMLS:C2711999

object_name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: UMLS:C2711999

object_name: Childhood Atypical Teratoid/Rhabdoid Tumor


subject: UMLS:C2711999

object_name: pediatric infratentorial ependymoma


subject: UMLS:C2711999

object_name: pediatric supratentorial ependymoma


subject: UMLS:C2711999

object_name: Childhood Cerebral Anaplastic Astrocytoma


subject: UMLS:C2711999

object_name: childhood cerebral astrocytoma


subject: UMLS:C2711999

object_name: Childhood Grade I Meningioma


subject: UMLS:C2711999

object_name: Childhood Grade III Meningioma


subject: UMLS:C2711999

object_name: childhood spinal cord tumor


subject: UMLS:C2711999

object_name: Childhood Grade II Meningioma


subject: UMLS:C2711999

object_name: childhood oligodendroglioma


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:M487QF2F4V

object_name: neurotoxicity


subject: UMLS:C1321603

subject_name: INJECTION, AMIFOSTINE, 500 MG ADMINISTERED


subject: UMLS:C1321603


subject: UMLS:C1321603

object_name: prostate carcinoma


subject: UMLS:C1321603

object_name: prostate cancer


subject: UMLS:C1321603

object_name: ovarian cancer


subject: UMLS:C1321603

object_name: ovarian neoplasm


subject: UMLS:C1321603

object_name: ovarian carcinoma


subject: UMLS:C1321603

object_name: Childhood Breast Carcinoma


subject: UMLS:C1321603

object_name: breast carcinoma


subject: UMLS:C1321603

object_name: breast cancer


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:31593

subject_name: fasudil hydrochloride


subject: CHEBI:43871

subject_name: Fasudil


subject: UMLS:C0526099


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: spastic diplegia


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IA Breast Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: stage IA breast cancer


subject: UNII:2S9ZZM9Q9V

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL5314982

subject_name: ECISKAFUSP ALFA

object_name: superficial urinary bladder carcinoma


subject: UMLS:C5446873


subject: UMLS:C4330852

subject_name: Oligomeric Procyanidin Complex

object_name: gingivitis


subject: CHEBI:61080

subject_name: Romidepsin

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:61080

object_name: Stage IV Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:61080

object_name: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: CHEBI:71196

subject_name: glucagon-like peptide-1 receptor agonist

object_name: pancreatic intraductal papillary-mucinous carcinoma


subject: CHEBI:71196

object_name: pancreatic intraductal papillary-mucinous neoplasm


subject: UMLS:C2917359

subject_name: GLP-1 Receptor Agonist [EPC]


subject: UMLS:C2917359


subject: GTOPDB:10492

subject_name: envafolimab

object_name: rectal carcinoma


subject: GTOPDB:10492

object_name: rectal cancer


subject: GTOPDB:10492

object_name: Childhood Rectal Carcinoma


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: CHEBI:94534

subject_name: olanzapine

object_name: Advanced Lung Carcinoma


subject: CHEBI:94534

object_name: Advanced Esophageal Carcinoma


subject: CHEBI:94534

object_name: Locally Advanced Colorectal Carcinoma


subject: CHEBI:94534

object_name: Locally Advanced Esophageal Carcinoma


subject: CHEBI:94534

object_name: Metastatic Esophageal Carcinoma


subject: CHEBI:94534

object_name: Locally Advanced Gastric Carcinoma


subject: CHEBI:94534

object_name: Advanced Biliary Tract Carcinoma


subject: CHEBI:94534

object_name: Advanced Bile Duct Carcinoma


subject: CHEBI:94534

object_name: Locally Advanced Biliary Tract Carcinoma


subject: CHEBI:94534

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C2347652

subject_name: Povidone-Iodine Solution

object_name: Postoperative infection


subject: PUBCHEM.COMPOUND:71853

subject_name: Chitosan

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:71853

object_name: Chronic uremia


subject: CHEBI:57704

subject_name: cationic chitosan


subject: CHEBI:57704


subject: CHEBI:16261

subject_name: chitosan


subject: CHEBI:16261


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: idiopathic nephrotic syndrome


subject: CHEBI:168396

object_name: lipoid nephrosis


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: PUBCHEM.COMPOUND:154824286

object_name: autosomal dominant polycystic kidney disease


subject: CHEMBL.COMPOUND:CHEMBL4650511


subject: PUBCHEM.COMPOUND:146219790

subject_name: atirmociclib

object_name: Carcinoma breast stage IV


subject: UMLS:C5966116

subject_name: Atirmociclib


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin


subject: UNII:L4C1UY2NYH

subject_name: Inavolisib


subject: CHEBI:95089

subject_name: Ipatasertib


subject: UMLS:C3827076


subject: CHEMBL.COMPOUND:CHEMBL2109477

subject_name: SELICRELUMAB


subject: UMLS:C1869412


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Refractory B Acute Lymphoblastic Leukemia, BCR-ABL1-Like


subject: PUBCHEM.COMPOUND:596

object_name: Recurrent B Acute Lymphoblastic Leukemia, BCR-ABL1-Like


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:70839

subject_name: Dasatinib


subject: CHEBI:70839

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: CHEBI:70839


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:31822


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:45783

subject_name: Imatinib

object_name: neoplasm


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: cancer


subject: CHEBI:49900


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UMLS:C4722503

subject_name: ODX

object_name: plasma cell myeloma


subject: PR:000007324

subject_name: oxaloacetate tautomerase FAHD1, mitochondrial


subject: UMLS:C3640299

subject_name: Osteodex


subject: CHEBI:63612

subject_name: Nelarabine

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:63612

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:63612

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:63612

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:63612

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:63612

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:63612

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:63612

object_name: MALT lymphoma


subject: CHEBI:63612

object_name: splenic marginal zone lymphoma


subject: CHEBI:63612

object_name: Waldenstrom macroglobulinemia


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase

object_name: B-cell adult acute lymphocytic leukemia


subject: UNII:7D96IR0PPM

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Malignant melanoma of skin of breast


subject: PUBCHEM.COMPOUND:121362450

object_name: Hepatic impairment


subject: DRUGBANK:DB18963

subject_name: Mitiperstat


subject: CHEBI:36704

subject_name: Imiquimod

object_name: metastatic melanoma


subject: CHEBI:36704

object_name: Stage IIIB Cutaneous Melanoma AJCC v7


subject: CHEBI:36704

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: CHEBI:36704

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C0701187

subject_name: Campto

object_name: metastatic colorectal cancer


subject: CHEBI:90998

subject_name: alvocidib hydrochloride

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:90998

object_name: prolymphocytic leukemia


subject: CHEBI:90998

object_name: Chronic lymphocytic leukaemia stage 1


subject: CHEBI:90998

object_name: B-cell small lymphocytic lymphoma stage I


subject: CHEBI:90998

object_name: Chronic lymphocytic leukaemia stage 2


subject: CHEBI:90998

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:90998

object_name: B-cell small lymphocytic lymphoma stage II


subject: CHEBI:90998

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:90998

object_name: Chronic lymphocytic leukaemia stage 3


subject: CHEBI:90998

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:90998

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:90998

object_name: Chronic lymphocytic leukaemia refractory


subject: UMLS:C2709282

subject_name: Alvocidib Hydrochloride


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:GK1LYB375A

subject_name: Tralokinumab

object_name: Uncontrolled asthma


subject: CHEBI:71954

subject_name: Buparlisib

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:N673F6W2VH

subject_name: Odanacatib

object_name: Metastatic Bone Disease


subject: UMLS:C5960870

subject_name: KRAS G12D Inhibitor QTX3046


subject: GTOPDB:13826

subject_name: pegcetacoplan

object_name: wet macular degeneration


subject: UNII:TO3JYR3BOU

subject_name: Pegcetacoplan


subject: UMLS:C4731369

subject_name: Symdeko

object_name: cystic fibrosis


subject: CHEBI:8499

subject_name: Propranolol

object_name: arteriosclerosis disorder


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Stress


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: CHEBI:135207

subject_name: Clofedanol


subject: CHEBI:135207


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEMBL.COMPOUND:CHEMBL5314814

subject_name: BUDOPRUTUG

object_name: EXCESS LMW-DNA


subject: CHEMBL.COMPOUND:CHEMBL5314814

object_name: st. Louis encephalitis


subject: UMLS:C5908921

subject_name: Budoprutug


subject: UMLS:C5908921


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: bronchopulmonary dysplasia


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:33330

subject_name: scandium atom


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: CHEBI:63622

subject_name: Sotalol

object_name: Arrhythmia


subject: CHEBI:71416

subject_name: phenazopyridine

object_name: Injury of ureter


subject: PUBCHEM.COMPOUND:135580740

subject_name: Phenazo


subject: UNII:K2J09EMJ52

subject_name: Phenazopyridine


subject: CHEBI:172923

subject_name: FLUORESCEIN


subject: UNII:M43ZDU10DD

subject_name: ICLEPERTIN

object_name: schizophrenia


subject: DRUGBANK:DB19058

subject_name: Iclepertin


subject: UMLS:C3888312

object_name: rheumatoid arthritis


subject: CHEBI:145371

subject_name: Binimetinib


subject: PUBCHEM.COMPOUND:135742497

subject_name: MEK inhibitor


subject: UMLS:C2347168

subject_name: Mitogen-Activated Protein Kinase Kinase Inhibitor


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:89324


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C5239569

subject_name: PhosphoLean

object_name: alcohol consumption (history)


subject: CHEBI:31413

subject_name: Clobazam

object_name: Drug Resistant Epilepsy


subject: CHEBI:16171

subject_name: NMN zwitterion

object_name: autoimmune thrombocytopenia


subject: CHEBI:16171

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:16171

object_name: autoimmune thrombocytopenic purpura


subject: PUBCHEM.COMPOUND:6093202

subject_name: Nicotinamide Mononucleotide


subject: PUBCHEM.COMPOUND:6093202


subject: PUBCHEM.COMPOUND:6093202


subject: CHEBI:14648

subject_name: NMN(+)


subject: CHEBI:14648


subject: CHEBI:14648


subject: CHEBI:3011

subject_name: Benazepril

object_name: proteinuria


subject: CHEBI:3011

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:3011

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:3011

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:2668

subject_name: Amlodipine

object_name: Diabetes


subject: CHEBI:2668

object_name: diabetes mellitus


subject: CHEBI:9649

subject_name: Trandolapril


subject: CHEBI:9649


subject: CHEBI:9649


subject: CHEBI:9649


subject: CHEBI:77733

subject_name: Verapamil


subject: CHEBI:77733


subject: CHEBI:77733


subject: CHEBI:77733


subject: CHEBI:84040

object_name: liver cancer


subject: CHEBI:84040

object_name: liver neoplasm


subject: CHEBI:84040

object_name: Adult Liver Carcinoma


subject: CHEBI:84040

object_name: liver carcinoma


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:36002


subject: CHEBI:36002


subject: CHEBI:36002


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:27881


subject: CHEBI:27881


subject: CHEBI:27881


subject: UNII:Q8LVL5Z68H

subject_name: VAPENDAVIR

object_name: upper respiratory tract disorder


subject: UNII:Q8LVL5Z68H

object_name: lower respiratory tract disorder


subject: UNII:Q8LVL5Z68H

object_name: Rhinovirus infection


subject: UNII:Q8LVL5Z68H

object_name: enterovirus infectious disease


subject: UNII:Q8LVL5Z68H

object_name: viral disease


subject: UNII:Q8LVL5Z68H

object_name: obstructive lung disease


subject: UNII:Q8LVL5Z68H

object_name: lung disorder


subject: UNII:Q8LVL5Z68H

object_name: History of - respiratory disease


subject: UNII:Q8LVL5Z68H

object_name: respiratory system disorder


subject: UNII:Q8LVL5Z68H

object_name: Chronic obstructive pulmonary disease of horses


subject: UNII:Q8LVL5Z68H

object_name: COPD, severe early onset


subject: UNII:Q8LVL5Z68H

object_name: chronic obstructive pulmonary disease


subject: UNII:Q8LVL5Z68H

object_name: Chronic disease of respiratory system


subject: UNII:Q8LVL5Z68H

object_name: common cold


subject: UNII:Q8LVL5Z68H

object_name: Chronic lung disease


subject: UNII:Q8LVL5Z68H

object_name: Upper Respiratory Infections


subject: UNII:Q8LVL5Z68H

object_name: respiratory tract infectious disorder


subject: UNII:Q8LVL5Z68H

object_name: Recurrent upper respiratory tract infections


subject: UNII:Q8LVL5Z68H

object_name: viral respiratory tract infection


subject: UNII:Q8LVL5Z68H

object_name: Non-Neoplastic Chronic Respiratory System Disorder


subject: UNII:Q8LVL5Z68H

object_name: chronic lower respiratory disease


subject: UNII:Q8LVL5Z68H

object_name: Infection


subject: UNII:Q8LVL5Z68H

object_name: Infection of musculoskeletal system


subject: UNII:Q8LVL5Z68H

object_name: Upper respiratory disease, acute


subject: UNII:Q8LVL5Z68H

object_name: Lower respiratory tract and lung infections


subject: UNII:Q8LVL5Z68H

object_name: Upper respiratory disorder


subject: UNII:Q8LVL5Z68H

object_name: RNA Virus Infections


subject: UNII:Q8LVL5Z68H

object_name: Respiratory complication


subject: UNII:Q8LVL5Z68H

object_name: Acute exacerbation of chronic obstructive pulmonary disease


subject: UNII:Q8LVL5Z68H

object_name: Emphysema or COPD


subject: UMLS:C4726944

subject_name: Vapendavir

object_name: upper respiratory tract disorder


subject: UMLS:C4726944

object_name: lower respiratory tract disorder


subject: UMLS:C4726944

object_name: Rhinovirus infection


subject: UMLS:C4726944

object_name: enterovirus infectious disease


subject: UMLS:C4726944

object_name: viral disease


subject: UMLS:C4726944

object_name: obstructive lung disease


subject: UMLS:C4726944

object_name: lung disorder


subject: UMLS:C4726944

object_name: History of - respiratory disease


subject: UMLS:C4726944

object_name: respiratory system disorder


subject: UMLS:C4726944

object_name: Chronic obstructive pulmonary disease of horses


subject: UMLS:C4726944

object_name: COPD, severe early onset


subject: UMLS:C4726944

object_name: chronic obstructive pulmonary disease


subject: UMLS:C4726944

object_name: Chronic disease of respiratory system


subject: UMLS:C4726944

object_name: common cold


subject: UMLS:C4726944

object_name: Chronic lung disease


subject: UMLS:C4726944

object_name: Upper Respiratory Infections


subject: UMLS:C4726944

object_name: respiratory tract infectious disorder


subject: UMLS:C4726944

object_name: Recurrent upper respiratory tract infections


subject: UMLS:C4726944

object_name: viral respiratory tract infection


subject: UMLS:C4726944

object_name: Non-Neoplastic Chronic Respiratory System Disorder


subject: UMLS:C4726944

object_name: chronic lower respiratory disease


subject: UMLS:C4726944

object_name: Infection


subject: UMLS:C4726944

object_name: Infection of musculoskeletal system


subject: UMLS:C4726944

object_name: Upper respiratory disease, acute


subject: UMLS:C4726944

object_name: Lower respiratory tract and lung infections


subject: UMLS:C4726944

object_name: Upper respiratory disorder


subject: UMLS:C4726944

object_name: RNA Virus Infections


subject: UMLS:C4726944

object_name: Respiratory complication


subject: UMLS:C4726944

object_name: Acute exacerbation of chronic obstructive pulmonary disease


subject: UMLS:C4726944

object_name: Emphysema or COPD


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: benign prostatic hyperplasia


subject: CHEBI:94518

object_name: urinary system disorder


subject: CHEBI:94518

object_name: Kidney Calculi


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Unknown Primary Tumors


subject: UMLS:C3541386

subject_name: Estrogens, endocrine therapy drugs

object_name: Unspecified injury of brachial artery, left side, initial encounter


subject: UMLS:C3537250

subject_name: ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM


subject: CHEBI:50114

subject_name: estrogen


subject: UMLS:C3714615

subject_name: Estrogens Drug Class


subject: UMLS:C0301869

subject_name: Immunostimulating conjugate (antigen)


subject: CHEBI:4305

subject_name: dacarbazine

object_name: small cell lung carcinoma


subject: CHEBI:4305

object_name: parathyroid gland carcinoma


subject: CHEBI:4305

object_name: carcinoid tumor


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:52717

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:52717

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:52717

object_name: soft tissue sarcoma


subject: CHEBI:52717


subject: CHEBI:52717


subject: CHEBI:52717


subject: CHEBI:95341

subject_name: Baricitinib

object_name: psoriasis


subject: CHEBI:95341

object_name: Skin Diseases, Papulosquamous


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Esophageal neoplasm metastatic


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:16681698

subject_name: Obatoclax mesylate

object_name: systemic mastocytosis


subject: PUBCHEM.COMPOUND:16681698

object_name: leukemia


subject: PUBCHEM.COMPOUND:16681698

object_name: childhood leukemia


subject: CHEBI:94522


subject: CHEBI:94522


subject: CHEBI:94522


subject: UNII:39200FJ43J

subject_name: [OBSOLETE] obatoclax mesylate


subject: UNII:39200FJ43J


subject: UNII:39200FJ43J


subject: UMLS:C1831948

subject_name: obatoclax mesylate


subject: UMLS:C1831948


subject: UMLS:C1831948


subject: PUBCHEM.COMPOUND:135582802

subject_name: CEFTOBIPROLE MEDOCARIL

object_name: pneumonia


subject: PUBCHEM.COMPOUND:135582802

object_name: COVID-19-Associated Pneumonia


subject: UNII:N99027V28J


subject: UNII:N99027V28J


subject: PUBCHEM.COMPOUND:135456161


subject: PUBCHEM.COMPOUND:135456161


subject: CHEBI:140407

subject_name: Ceftobiprole


subject: CHEBI:140407


subject: CHEBI:135594

subject_name: Limaprost

object_name: Cervical myelopathy


subject: PUBCHEM.COMPOUND:24748

subject_name: Croscarmellose

object_name: Dry Eye, CTCAE


subject: PUBCHEM.COMPOUND:24748

object_name: Dryness of eye


subject: CHEBI:31357

subject_name: Carboxymethylcellulose cellulose carboxymethyl ether


subject: CHEBI:31357


subject: CHEMBL.COMPOUND:CHEMBL2109001

subject_name: CARBOXYMETHYLCELLULOSE SODIUM


subject: CHEMBL.COMPOUND:CHEMBL2109001


subject: UNII:K679OBS311

subject_name: Carboxymethylcellulose Sodium


subject: UNII:K679OBS311


subject: CHEBI:17754

subject_name: Glycerin


subject: CHEBI:17754


subject: UMLS:C3854326

subject_name: Janus Kinase Inhibitor [EPC]

object_name: rheumatoid arthritis


subject: CHEBI:90620

subject_name: Vatalanib

object_name: prostate carcinoma


subject: CHEBI:90620

object_name: prostate cancer


subject: UMLS:C0912413

subject_name: PTK 787


subject: UMLS:C0912413


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:45716

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:45716

object_name: sarcoma


subject: CHEBI:45716

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:45716

object_name: soft tissue sarcoma


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: Clinically isolated syndrome


subject: CHEMBL.COMPOUND:CHEMBL5314359

subject_name: ERTAPENEM SODIUM

object_name: Diabetic foot infection


subject: CHEBI:404903

subject_name: Ertapenem


subject: UNII:X00B0D5O0E

subject_name: PIPERACILLIN


subject: CHEBI:8232

subject_name: Piperacillin


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Tobacco use in mother complicating childbirth


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: pregnancy related


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: patent ductus arteriosus


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C3536840

subject_name: Nonsteroidal Anti-inflammatory Drug [EPC]


subject: CHEBI:45367

subject_name: Rifabutin

object_name: coronary artery disorder


subject: CHEBI:45367

object_name: Chlamydophila pneumoniae infections


subject: UNII:2285XW22DR

subject_name: cixutumumab

object_name: Small cell lung cancer extensive stage


subject: UNII:2285XW22DR

object_name: Small cell lung cancer recurrent


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: CHEBI:66903

subject_name: Vismodegib


subject: CHEBI:66903


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: substance-related disorder


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:135931

subject_name: Dexlansoprazole

object_name: Hypertrophy of lingual tonsil


subject: CHEBI:9637

subject_name: Torasemide

object_name: type 2 diabetes mellitus


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Locally Advanced Esophageal Squamous Cell Carcinoma


subject: UMLS:C2346820


subject: CHEBI:149504

object_name: heart failure


subject: CHEBI:149504

object_name: Heart Failure, CTCAE


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: drug rash with eosinophilia and systemic symptoms


subject: CHEBI:8382

subject_name: Prednisone


subject: UNII:Y333RS1786

subject_name: Cenerimod

object_name: kidney failure


subject: UMLS:C3864947

subject_name: Gardasil 9

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:49800000

subject_name: MECLIZINE HYDROCHLORIDE

object_name: Vomiting


subject: CHEBI:6709

subject_name: Meclizine


subject: UMLS:C4053615

object_name: neoplasm


subject: CHEBI:28838

subject_name: Lutein

object_name: open-angle glaucoma


subject: CHEBI:27547

subject_name: Zeaxanthin


subject: CHEBI:63631

subject_name: Topiramate

object_name: Tabagism


subject: CHEBI:31859

subject_name: Modafinil

object_name: sleep disorder, initiating and maintaining sleep


subject: CHEBI:31859

object_name: Alzheimer disease type 1


subject: CHEBI:64356

subject_name: Pregabalin

object_name: post operative nausea and vomiting


subject: CHEBI:64356

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:64356

object_name: obesity


subject: CHEBI:64356

object_name: Obesity, CTCAE


subject: PR:000007632

subject_name: forkhead box protein K2

object_name: metastatic neoplasm


subject: PR:000007632

object_name: Metastatic Lesion


subject: PR:000007632

object_name: gastric neoplasm


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: GTOPDB:13792

subject_name: iparomlimab

object_name: non-small cell lung carcinoma


subject: UNII:FN3VWV28BC

subject_name: IPAROMLIMAB


subject: UMLS:C5669553

subject_name: Iparomlimab


subject: GTOPDB:13793

subject_name: tuvonralimab


subject: UNII:8XWO7LI4LO

subject_name: TUVONRALIMAB


subject: UMLS:C5784793

subject_name: Tuvonralimab


subject: UMLS:C4527194

subject_name: Protease Inhibitor Formulation LB1148

object_name: digestive system disorder


subject: PUBCHEM.COMPOUND:2008

subject_name: Aclacinomycin A zwitterion

object_name: retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations


subject: CHEBI:74619

subject_name: Aclarubicin


subject: UMLS:C5666968

subject_name: KRAS G12C Inhibitor MK-1084

object_name: kidney failure


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Upper gastrointestinal hemorrhage


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: schistosomiasis


subject: CHEBI:75832

object_name: helminthiasis


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UNII:5ZHA5P4PFX

subject_name: Dalpiciclib

object_name: Early Stage Breast Carcinoma


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: Sepsis


subject: CHEBI:30314

object_name: Sepsis, CTCAE


subject: CHEBI:17460

subject_name: Thioctamide


subject: CHEBI:17460


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:16494


subject: CHEBI:3112

subject_name: Biperiden

object_name: traumatic encephalopathy


subject: CHEBI:3112

object_name: traumatic brain injury


subject: CHEBI:73461

subject_name: Cys-Pro

object_name: Childhood Breast Carcinoma


subject: CHEBI:73461

object_name: breast carcinoma


subject: CHEBI:73461

object_name: breast cancer


subject: CHEBI:30663

subject_name: cyclopentadienyl group


subject: CHEBI:30663


subject: CHEBI:30663


subject: CHEBI:16486

subject_name: cyclopentanone


subject: CHEBI:16486


subject: CHEBI:16486


subject: CHEBI:3380

subject_name: Captopril


subject: CHEBI:3380


subject: CHEBI:3380


subject: PUBCHEM.COMPOUND:450601

subject_name: Fluciclovine (18F)

object_name: metastatic malignant neoplasm in the brain


subject: PUBCHEM.COMPOUND:450601

object_name: Metastatic Adult Malignant Neoplasm in the Brain


subject: PUBCHEM.COMPOUND:450601

object_name: brain cancer


subject: PUBCHEM.COMPOUND:10820564

subject_name: Fluciclovine


subject: PUBCHEM.COMPOUND:10820564


subject: PUBCHEM.COMPOUND:10820564


subject: CHEBI:134703


subject: UMLS:C4721874

subject_name: human insulin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C4721874

object_name: obesity


subject: UMLS:C4721874

object_name: Obesity, CTCAE


subject: CHEBI:3423

subject_name: Carmustine

object_name: prolymphocytic leukemia


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:4911

subject_name: Etoposide


subject: PUBCHEM.COMPOUND:56971685

subject_name: Relebactam

object_name: Abdominal Infection


subject: CHEBI:50162

subject_name: motexafin gadolinium hydrate

object_name: Non-small cell lung cancer stage IIIA


subject: PUBCHEM.COMPOUND:9919910

subject_name: Xcytrin


subject: CHEBI:33375

subject_name: Gadolinium


subject: CHEMBL.COMPOUND:CHEMBL3544910

subject_name: MOTEXAFIN GADOLINIUM


subject: CHEBI:7514

subject_name: Neostigmine

object_name: Complication of anesthesia


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Mantle cell lymphoma refractory


subject: CHEBI:79699

object_name: Marginal zone lymphoma refractory


subject: CHEBI:79699

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:79699

object_name: Follicular lymphoma refractory


subject: CHEBI:79699

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:79699


subject: CHEBI:79699

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:79699

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:79699

object_name: Follicular lymphoma recurrent


subject: CHEBI:79699

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:79699

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:79699

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:79699

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: chronic obstructive pulmonary disease


subject: CHEBI:73604

object_name: alpha 1-antitrypsin deficiency


subject: UNII:NA1U919MRO

subject_name: Difelikefalin

object_name: Pruritus, CTCAE


subject: UNII:NA1U919MRO

object_name: Pruritus


subject: UNII:NA1U919MRO

object_name: chronic kidney disease


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: Infection following immunization


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: UMLS:C5395271

subject_name: Vaccine product containing only Influenza virus antigen (medicinal product)


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: Recurrent Platinum-Resistant Primary Peritoneal Carcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Platinum-Resistant Fallopian Tube Carcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Platinum-Resistant Ovarian Carcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Primary Peritoneal Transitional Cell Carcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Primary Peritoneal Undifferentiated Carcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Primary Peritoneal Clear Cell Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Fallopian Tube Undifferentiated Carcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Fallopian Tube Transitional Cell Carcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Primary Peritoneal Endometrioid Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Fallopian Tube Clear Cell Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Refractory Primary Peritoneal Transitional Cell Carcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Platinum-Refractory Primary Peritoneal Carcinoma


subject: UNII:68AYS9A614

object_name: Platinum-Refractory Fallopian Tube Carcinoma


subject: UNII:68AYS9A614

object_name: Refractory Primary Peritoneal Undifferentiated Carcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Fallopian Tube Mucinous Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Ovarian Undifferentiated Carcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Ovarian Transitional Cell Carcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Fallopian Tube Endometrioid Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Refractory Primary Peritoneal Clear Cell Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Ovarian Clear Cell Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Refractory Fallopian Tube Undifferentiated Carcinoma


subject: UNII:68AYS9A614

object_name: Refractory Fallopian Tube Transitional Cell Carcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Fallopian Tube High Grade Serous Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Platinum-Refractory Ovarian Carcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Ovarian Endometrioid Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Refractory Fallopian Tube Clear Cell Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Refractory Primary Peritoneal Endometrioid Adenocarcinoma


subject: UNII:68AYS9A614

object_name: fallopian tube mucinous adenocarcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Ovarian Seromucinous Carcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Ovarian Mucinous Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Refractory Primary Peritoneal High Grade Serous Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Refractory Fallopian Tube Mucinous Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Refractory Fallopian Tube Endometrioid Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Ovarian Low Grade Serous Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Recurrent Ovarian High Grade Serous Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Refractory Low Grade Fallopian Tube Serous Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Refractory Fallopian Tube High Grade Serous Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Refractory Ovarian Undifferentiated Carcinoma


subject: UNII:68AYS9A614

object_name: Refractory Ovarian Transitional Cell Carcinoma


subject: UNII:68AYS9A614

object_name: Refractory Ovarian Clear Cell Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Refractory Ovarian Endometrioid Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Refractory Ovarian Seromucinous Carcinoma


subject: UNII:68AYS9A614

object_name: Refractory Ovarian Mucinous Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Refractory Ovarian Low Grade Serous Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Refractory Ovarian High Grade Serous Adenocarcinoma


subject: UMLS:C2711999

subject_name: cediranib maleate

object_name: Recurrent Platinum-Resistant Primary Peritoneal Carcinoma


subject: UMLS:C2711999

object_name: Recurrent Platinum-Resistant Fallopian Tube Carcinoma


subject: UMLS:C2711999

object_name: Recurrent Platinum-Resistant Ovarian Carcinoma


subject: UMLS:C2711999

object_name: Recurrent Primary Peritoneal Transitional Cell Carcinoma


subject: UMLS:C2711999

object_name: Recurrent Primary Peritoneal Undifferentiated Carcinoma


subject: UMLS:C2711999

object_name: Recurrent Primary Peritoneal Clear Cell Adenocarcinoma


subject: UMLS:C2711999

object_name: Recurrent Fallopian Tube Undifferentiated Carcinoma


subject: UMLS:C2711999

object_name: Recurrent Fallopian Tube Transitional Cell Carcinoma


subject: UMLS:C2711999

object_name: Recurrent Primary Peritoneal Endometrioid Adenocarcinoma


subject: UMLS:C2711999

object_name: Recurrent Fallopian Tube Clear Cell Adenocarcinoma


subject: UMLS:C2711999

object_name: Refractory Primary Peritoneal Transitional Cell Carcinoma


subject: UMLS:C2711999

object_name: Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma


subject: UMLS:C2711999

object_name: Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma


subject: UMLS:C2711999

object_name: Platinum-Refractory Primary Peritoneal Carcinoma


subject: UMLS:C2711999

object_name: Platinum-Refractory Fallopian Tube Carcinoma


subject: UMLS:C2711999

object_name: Refractory Primary Peritoneal Undifferentiated Carcinoma


subject: UMLS:C2711999

object_name: Recurrent Fallopian Tube Mucinous Adenocarcinoma


subject: UMLS:C2711999

object_name: Recurrent Ovarian Undifferentiated Carcinoma


subject: UMLS:C2711999

object_name: Recurrent Ovarian Transitional Cell Carcinoma


subject: UMLS:C2711999

object_name: Recurrent Fallopian Tube Endometrioid Adenocarcinoma


subject: UMLS:C2711999

object_name: Refractory Primary Peritoneal Clear Cell Adenocarcinoma


subject: UMLS:C2711999

object_name: Recurrent Ovarian Clear Cell Adenocarcinoma


subject: UMLS:C2711999

object_name: Refractory Fallopian Tube Undifferentiated Carcinoma


subject: UMLS:C2711999

object_name: Refractory Fallopian Tube Transitional Cell Carcinoma


subject: UMLS:C2711999

object_name: Recurrent Fallopian Tube High Grade Serous Adenocarcinoma


subject: UMLS:C2711999

object_name: Platinum-Refractory Ovarian Carcinoma


subject: UMLS:C2711999

object_name: Recurrent Ovarian Endometrioid Adenocarcinoma


subject: UMLS:C2711999

object_name: Refractory Fallopian Tube Clear Cell Adenocarcinoma


subject: UMLS:C2711999

object_name: Refractory Primary Peritoneal Endometrioid Adenocarcinoma


subject: UMLS:C2711999

object_name: fallopian tube mucinous adenocarcinoma


subject: UMLS:C2711999

object_name: Recurrent Ovarian Seromucinous Carcinoma


subject: UMLS:C2711999

object_name: Recurrent Ovarian Mucinous Adenocarcinoma


subject: UMLS:C2711999

object_name: Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma


subject: UMLS:C2711999

object_name: Refractory Primary Peritoneal High Grade Serous Adenocarcinoma


subject: UMLS:C2711999

object_name: Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma


subject: UMLS:C2711999

object_name: Refractory Fallopian Tube Mucinous Adenocarcinoma


subject: UMLS:C2711999

object_name: Refractory Fallopian Tube Endometrioid Adenocarcinoma


subject: UMLS:C2711999

object_name: Recurrent Ovarian Low Grade Serous Adenocarcinoma


subject: UMLS:C2711999

object_name: Recurrent Ovarian High Grade Serous Adenocarcinoma


subject: UMLS:C2711999

object_name: Refractory Low Grade Fallopian Tube Serous Adenocarcinoma


subject: UMLS:C2711999

object_name: Refractory Fallopian Tube High Grade Serous Adenocarcinoma


subject: UMLS:C2711999

object_name: Refractory Ovarian Undifferentiated Carcinoma


subject: UMLS:C2711999

object_name: Refractory Ovarian Transitional Cell Carcinoma


subject: UMLS:C2711999

object_name: Refractory Ovarian Clear Cell Adenocarcinoma


subject: UMLS:C2711999

object_name: Refractory Ovarian Endometrioid Adenocarcinoma


subject: UMLS:C2711999

object_name: Refractory Ovarian Seromucinous Carcinoma


subject: UMLS:C2711999

object_name: Refractory Ovarian Mucinous Adenocarcinoma


subject: UMLS:C2711999

object_name: Refractory Ovarian Low Grade Serous Adenocarcinoma


subject: UMLS:C2711999

object_name: Refractory Ovarian High Grade Serous Adenocarcinoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Recurrent Platinum-Resistant Primary Peritoneal Carcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Platinum-Resistant Fallopian Tube Carcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Platinum-Resistant Ovarian Carcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Primary Peritoneal Transitional Cell Carcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Primary Peritoneal Undifferentiated Carcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Primary Peritoneal Clear Cell Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Fallopian Tube Undifferentiated Carcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Fallopian Tube Transitional Cell Carcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Primary Peritoneal Endometrioid Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Fallopian Tube Clear Cell Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Primary Peritoneal Transitional Cell Carcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Platinum-Refractory Primary Peritoneal Carcinoma


subject: UNII:28X28X9OKV

object_name: Platinum-Refractory Fallopian Tube Carcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Primary Peritoneal Undifferentiated Carcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Fallopian Tube Mucinous Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Ovarian Undifferentiated Carcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Ovarian Transitional Cell Carcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Fallopian Tube Endometrioid Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Primary Peritoneal Clear Cell Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Ovarian Clear Cell Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Fallopian Tube Undifferentiated Carcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Fallopian Tube Transitional Cell Carcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Fallopian Tube High Grade Serous Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Platinum-Refractory Ovarian Carcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Ovarian Endometrioid Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Fallopian Tube Clear Cell Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Primary Peritoneal Endometrioid Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: fallopian tube mucinous adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Ovarian Seromucinous Carcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Ovarian Mucinous Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Primary Peritoneal High Grade Serous Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Fallopian Tube Mucinous Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Fallopian Tube Endometrioid Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Ovarian Low Grade Serous Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Ovarian High Grade Serous Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Low Grade Fallopian Tube Serous Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Fallopian Tube High Grade Serous Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Ovarian Undifferentiated Carcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Ovarian Transitional Cell Carcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Ovarian Clear Cell Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Ovarian Endometrioid Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Ovarian Seromucinous Carcinoma


subject: UNII:28X28X9OKV

object_name: ovarian seromucinous carcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Ovarian Mucinous Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Ovarian Low Grade Serous Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Ovarian High Grade Serous Adenocarcinoma


subject: UMLS:C3641122

object_name: Recurrent Platinum-Resistant Primary Peritoneal Carcinoma


subject: UMLS:C3641122

object_name: Recurrent Platinum-Resistant Fallopian Tube Carcinoma


subject: UMLS:C3641122

object_name: Recurrent Platinum-Resistant Ovarian Carcinoma


subject: UMLS:C3641122

object_name: Recurrent Primary Peritoneal Transitional Cell Carcinoma


subject: UMLS:C3641122

object_name: Recurrent Primary Peritoneal Undifferentiated Carcinoma


subject: UMLS:C3641122

object_name: Recurrent Primary Peritoneal Clear Cell Adenocarcinoma


subject: UMLS:C3641122

object_name: Recurrent Fallopian Tube Undifferentiated Carcinoma


subject: UMLS:C3641122

object_name: Recurrent Fallopian Tube Transitional Cell Carcinoma


subject: UMLS:C3641122

object_name: Recurrent Primary Peritoneal Endometrioid Adenocarcinoma


subject: UMLS:C3641122

object_name: Recurrent Fallopian Tube Clear Cell Adenocarcinoma


subject: UMLS:C3641122

object_name: Refractory Primary Peritoneal Transitional Cell Carcinoma


subject: UMLS:C3641122

object_name: Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma


subject: UMLS:C3641122

object_name: Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma


subject: UMLS:C3641122

object_name: Platinum-Refractory Primary Peritoneal Carcinoma


subject: UMLS:C3641122

object_name: Platinum-Refractory Fallopian Tube Carcinoma


subject: UMLS:C3641122

object_name: Refractory Primary Peritoneal Undifferentiated Carcinoma


subject: UMLS:C3641122

object_name: Recurrent Fallopian Tube Mucinous Adenocarcinoma


subject: UMLS:C3641122

object_name: Recurrent Ovarian Undifferentiated Carcinoma


subject: UMLS:C3641122

object_name: Recurrent Ovarian Transitional Cell Carcinoma


subject: UMLS:C3641122

object_name: Recurrent Fallopian Tube Endometrioid Adenocarcinoma


subject: UMLS:C3641122

object_name: Refractory Primary Peritoneal Clear Cell Adenocarcinoma


subject: UMLS:C3641122

object_name: Recurrent Ovarian Clear Cell Adenocarcinoma


subject: UMLS:C3641122

object_name: Refractory Fallopian Tube Undifferentiated Carcinoma


subject: UMLS:C3641122

object_name: Refractory Fallopian Tube Transitional Cell Carcinoma


subject: UMLS:C3641122

object_name: Recurrent Fallopian Tube High Grade Serous Adenocarcinoma


subject: UMLS:C3641122

object_name: Platinum-Refractory Ovarian Carcinoma


subject: UMLS:C3641122

object_name: Recurrent Ovarian Endometrioid Adenocarcinoma


subject: UMLS:C3641122

object_name: Refractory Fallopian Tube Clear Cell Adenocarcinoma


subject: UMLS:C3641122

object_name: Refractory Primary Peritoneal Endometrioid Adenocarcinoma


subject: UMLS:C3641122

object_name: fallopian tube mucinous adenocarcinoma


subject: UMLS:C3641122

object_name: Recurrent Ovarian Seromucinous Carcinoma


subject: UMLS:C3641122

object_name: Recurrent Ovarian Mucinous Adenocarcinoma


subject: UMLS:C3641122

object_name: Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma


subject: UMLS:C3641122

object_name: Refractory Primary Peritoneal High Grade Serous Adenocarcinoma


subject: UMLS:C3641122

object_name: Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma


subject: UMLS:C3641122

object_name: Refractory Fallopian Tube Mucinous Adenocarcinoma


subject: UMLS:C3641122

object_name: Refractory Fallopian Tube Endometrioid Adenocarcinoma


subject: UMLS:C3641122

object_name: Recurrent Ovarian Low Grade Serous Adenocarcinoma


subject: UMLS:C3641122

object_name: Recurrent Ovarian High Grade Serous Adenocarcinoma


subject: UMLS:C3641122

object_name: Refractory Low Grade Fallopian Tube Serous Adenocarcinoma


subject: UMLS:C3641122

object_name: Refractory Fallopian Tube High Grade Serous Adenocarcinoma


subject: UMLS:C3641122

object_name: Refractory Ovarian Undifferentiated Carcinoma


subject: UMLS:C3641122

object_name: Refractory Ovarian Transitional Cell Carcinoma


subject: UMLS:C3641122

object_name: Refractory Ovarian Clear Cell Adenocarcinoma


subject: UMLS:C3641122

object_name: Refractory Ovarian Endometrioid Adenocarcinoma


subject: UMLS:C3641122

object_name: Refractory Ovarian Seromucinous Carcinoma


subject: UMLS:C3641122

object_name: ovarian seromucinous carcinoma


subject: UMLS:C3641122

object_name: Refractory Ovarian Mucinous Adenocarcinoma


subject: UMLS:C3641122

object_name: Refractory Ovarian Low Grade Serous Adenocarcinoma


subject: UMLS:C3641122

object_name: Refractory Ovarian High Grade Serous Adenocarcinoma


subject: CHEBI:83766

subject_name: Olaparib

object_name: Recurrent Primary Peritoneal Transitional Cell Carcinoma


subject: CHEBI:83766

object_name: Recurrent Primary Peritoneal Undifferentiated Carcinoma


subject: CHEBI:83766

object_name: Recurrent Primary Peritoneal Clear Cell Adenocarcinoma


subject: CHEBI:83766

object_name: Recurrent Fallopian Tube Undifferentiated Carcinoma


subject: CHEBI:83766

object_name: Recurrent Fallopian Tube Transitional Cell Carcinoma


subject: CHEBI:83766

object_name: Recurrent Fallopian Tube Clear Cell Adenocarcinoma


subject: CHEBI:83766

object_name: Refractory Primary Peritoneal Transitional Cell Carcinoma


subject: CHEBI:83766

object_name: Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma


subject: CHEBI:83766

object_name: Refractory Primary Peritoneal Undifferentiated Carcinoma


subject: CHEBI:83766

object_name: Recurrent Fallopian Tube Mucinous Adenocarcinoma


subject: CHEBI:83766

object_name: Recurrent Ovarian Undifferentiated Carcinoma


subject: CHEBI:83766

object_name: Recurrent Ovarian Transitional Cell Carcinoma


subject: CHEBI:83766

object_name: Refractory Primary Peritoneal Clear Cell Adenocarcinoma


subject: CHEBI:83766

object_name: Recurrent Ovarian Clear Cell Adenocarcinoma


subject: CHEBI:83766

object_name: Refractory Fallopian Tube Undifferentiated Carcinoma


subject: CHEBI:83766

object_name: Refractory Fallopian Tube Transitional Cell Carcinoma


subject: CHEBI:83766

object_name: Refractory Fallopian Tube Clear Cell Adenocarcinoma


subject: CHEBI:83766

object_name: Refractory Primary Peritoneal Endometrioid Adenocarcinoma


subject: CHEBI:83766

object_name: fallopian tube mucinous adenocarcinoma


subject: CHEBI:83766

object_name: Recurrent Ovarian Seromucinous Carcinoma


subject: CHEBI:83766

object_name: Recurrent Ovarian Mucinous Adenocarcinoma


subject: CHEBI:83766

object_name: Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma


subject: CHEBI:83766

object_name: Refractory Primary Peritoneal High Grade Serous Adenocarcinoma


subject: CHEBI:83766

object_name: Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma


subject: CHEBI:83766

object_name: Refractory Fallopian Tube Mucinous Adenocarcinoma


subject: CHEBI:83766

object_name: Refractory Fallopian Tube Endometrioid Adenocarcinoma


subject: CHEBI:83766

object_name: Recurrent Ovarian Low Grade Serous Adenocarcinoma


subject: CHEBI:83766

object_name: Refractory Low Grade Fallopian Tube Serous Adenocarcinoma


subject: CHEBI:83766

object_name: Refractory Ovarian Undifferentiated Carcinoma


subject: CHEBI:83766

object_name: Refractory Ovarian Transitional Cell Carcinoma


subject: CHEBI:83766

object_name: Refractory Ovarian Clear Cell Adenocarcinoma


subject: CHEBI:83766

object_name: Refractory Ovarian Endometrioid Adenocarcinoma


subject: CHEBI:83766

object_name: Refractory Ovarian Seromucinous Carcinoma


subject: CHEBI:83766

object_name: Refractory Ovarian Mucinous Adenocarcinoma


subject: CHEBI:83766

object_name: Refractory Ovarian Low Grade Serous Adenocarcinoma


subject: CHEBI:83766

object_name: Refractory Ovarian High Grade Serous Adenocarcinoma


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Heart failure with mid range ejection fraction


subject: CHEBI:9241

object_name: Heart failure with midrange ejection fraction


subject: CHEBI:9241

object_name: Heart failure with normal ejection fraction


subject: UNII:K82DG47I0G

subject_name: PEXASTIMOGENE DEVACIREPVEC

object_name: nonpapillary renal cell carcinoma


subject: UNII:K82DG47I0G

object_name: clear cell renal carcinoma


subject: UNII:K82DG47I0G

object_name: renal cell adenocarcinoma


subject: UNII:K82DG47I0G

object_name: renal cell carcinoma


subject: UMLS:C4722744

subject_name: Pexa-vec


subject: UMLS:C4722744


subject: UMLS:C4722744


subject: UMLS:C4722744


subject: CHEBI:18358

subject_name: Methoxsalen

object_name: Crohn disease


subject: PR:000014047

subject_name: eosinophil cationic protein


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: gastritis h pylori


subject: CHEBI:51254

object_name: Bacterial resistance


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:3732

subject_name: Clarithromycin


subject: CHEBI:3732


subject: CHEBI:50275

subject_name: Esomeprazole


subject: CHEBI:50275


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: PUBCHEM.COMPOUND:135415564

subject_name: Rifabutin

object_name: Helicobacter pylori infectious disease


subject: PUBCHEM.COMPOUND:135415564


subject: PUBCHEM.COMPOUND:135415564


subject: CHEBI:45367


subject: CHEBI:45367


subject: CHEBI:45367


subject: CHEBI:63627

subject_name: Tinidazole


subject: CHEBI:63627


subject: CHEBI:63627


subject: UMLS:C3897147

object_name: urothelial carcinoma


subject: UMLS:C3897147

object_name: transitional cell carcinoma


subject: CHEBI:31898

subject_name: Nedaplatin

object_name: Locally Advanced Esophageal Squamous Cell Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3137685

subject_name: NEDAPLATIN


subject: UMLS:C5207052

subject_name: Paclitaxel Albumin


subject: UNII:SE2KH7T06F

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage III Breast Cancer AJCC v6


subject: UMLS:C2826229

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C2826229

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C2826229

object_name: Stage III Breast Cancer AJCC v7


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C2826229

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C2826229

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C2826229

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C2826229

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C2826229

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C2826229

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C2826229

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C2826229

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C2826229

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601

object_name: Breast cancer stage III


subject: CHEBI:231601


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: GTOPDB:9244

subject_name: utomilumab

object_name: HER2 positive breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3707324

subject_name: UTOMILUMAB


subject: UMLS:C3529795


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: Luteal phase defect


subject: CHEBI:31527

object_name: implantation; placenta


subject: CHEBI:31527

object_name: abortion


subject: CHEBI:31527

object_name: Pregnancy loss


subject: CHEBI:31527

object_name: Pregnancy Loss, CTCAE


subject: UMLS:C0591419

subject_name: Duphaston


subject: UMLS:C0591419


subject: UMLS:C0591419


subject: UMLS:C0591419


subject: UMLS:C0591419


subject: CHEBI:9168

subject_name: Sirolimus

object_name: schizophrenia


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Narcotic Abuse


subject: CHEBI:7465

object_name: chronic pain (diagnosis)


subject: CHEBI:7465

object_name: Chronic pain


subject: UNII:7K28NB895L

subject_name: Belzutifan

object_name: Renal cell carcinoma recurrent


subject: UNII:7K28NB895L

object_name: renal carcinoma


subject: UNII:7K28NB895L

object_name: kidney cancer


subject: UNII:7K28NB895L

object_name: Renal cancer recurrent


subject: UNII:7K28NB895L

object_name: Metastatic Renal Cell Carcinoma


subject: UNII:7K28NB895L

object_name: Metastatic Renal Cell Cancer


subject: UNII:7K28NB895L

object_name: kidney neoplasm


subject: UNII:7K28NB895L

object_name: Neoplasm of uncertain or unknown behavior of kidney


subject: UNII:7K28NB895L

object_name: kidney benign neoplasm


subject: UNII:7K28NB895L

object_name: Kidney problem


subject: CHEBI:72317

subject_name: Cabozantinib


subject: CHEBI:72317


subject: CHEBI:72317


subject: CHEBI:72317


subject: CHEBI:94463

object_name: Hepatitis C relapse


subject: CHEBI:63580

subject_name: Ribavirin


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: abdominal aortic aneurysm


subject: UMLS:C0085155

subject_name: Generic Drugs


subject: CHEBI:7476

subject_name: Naproxen


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: Unresectable Hepatocellular Carcinoma


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: UNII:9RV78Q2002

subject_name: Vedolizumab

object_name: collagenous gastritis


subject: UMLS:C1098513


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: metastatic gastrointestinal carcinoid tumor


subject: PUBCHEM.COMPOUND:70789204

object_name: Non-small cell lung cancer recurrent


subject: PUBCHEM.COMPOUND:70789204

object_name: Metastatic non-small cell lung cancer


subject: PUBCHEM.COMPOUND:70789204

object_name: metastatic pheochromocytoma


subject: PUBCHEM.COMPOUND:70789204

object_name: malignant adrenal gland pheochromocytoma


subject: PUBCHEM.COMPOUND:70789204

object_name: recurrent pheochromocytoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Melanoma recurrent


subject: PUBCHEM.COMPOUND:70789204

object_name: Metastatic Cutaneous Melanoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:90620

subject_name: Vatalanib

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:90620

object_name: PPoma


subject: CHEBI:90620

object_name: stage III Merkel cell carcinoma


subject: CHEBI:90620

object_name: Recurrent Merkel Cell Carcinoma


subject: CHEBI:90620

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: CHEBI:90620

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: CHEBI:90620


subject: CHEBI:90620


subject: CHEBI:90620


subject: CHEBI:90620

object_name: Renal cell carcinoma recurrent


subject: CHEBI:90620

object_name: Renal cancer recurrent


subject: CHEBI:90620

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:90620

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:90620

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:90620

object_name: recurrent islet cell carcinoma


subject: CHEBI:90620

object_name: medullary thyroid gland carcinoma


subject: CHEBI:90620

object_name: metastatic pheochromocytoma


subject: CHEBI:90620

object_name: malignant adrenal gland pheochromocytoma


subject: CHEBI:90620

object_name: recurrent pheochromocytoma


subject: CHEBI:90620

object_name: Melanoma recurrent


subject: CHEBI:90620

object_name: pancreatic neoplasm of uncertain behavior somatostatinoma


subject: CHEBI:90620

object_name: pancreatic somatostatinoma


subject: CHEBI:90620

object_name: somatostatinoma


subject: CHEBI:90620

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:90620

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:90620

object_name: metastatic melanoma


subject: CHEBI:90620

object_name: glucagonoma


subject: CHEBI:90620

object_name: Zollinger-Ellison syndrome


subject: CHEBI:90620

object_name: gastrinoma


subject: CHEBI:90620

object_name: pancreatic gastrinoma


subject: CHEBI:90620

object_name: insulinoma


subject: CHEBI:30430

subject_name: indium atom

object_name: Narcotic Abuse


subject: CHEBI:74063

subject_name: Ile-Asn


subject: CHEBI:30429

subject_name: Indium


subject: CHEBI:33124


subject: CHEBI:29315

subject_name: phosphoryl


subject: CHEBI:33125


subject: PUBCHEM.COMPOUND:58827053

subject_name: Osilodrostat

object_name: kidney failure


subject: CHEBI:51141

subject_name: Alfuzosin

object_name: prostate disorder


subject: UMLS:C0003250

subject_name: Monoclonal Antibodies

object_name: urologic injuries


subject: UMLS:C0003250

object_name: male reproductive system disorder


subject: UMLS:C5203232

subject_name: Monoclonal Antibody [EPC]


subject: UMLS:C5203232


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: PUBCHEM.COMPOUND:5378597

object_name: sickle cell disease


subject: PUBCHEM.COMPOUND:5378597

object_name: Sickle cell-beta^0^-thalassemia


subject: CHEBI:68352

subject_name: Isoquercetin


subject: CHEBI:68352


subject: CHEBI:135005

subject_name: Milnacipran

object_name: Low back pain


subject: UMLS:C5434105

subject_name: Injection, sacituzumab govitecan-hziy, 2.5 mg

object_name: Childhood Solid Neoplasm


subject: UMLS:C5434105

object_name: Solid Neoplasm


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C4724862

subject_name: Aurixim

object_name: follicular lymphoma


subject: UMLS:C4724862

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C4724862

object_name: non-Hodgkin lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108905

subject_name: BCG VACCINE

object_name: Immunity, Innate


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: PUBCHEM.COMPOUND:16131310

subject_name: Hepatitis B Vaccines


subject: DRUGBANK:DB11627

subject_name: Hepatitis B Vaccine (Recombinant)


subject: UMLS:C2240392


subject: UMLS:C0062527

subject_name: Engerix-B


subject: CHEBI:9144

subject_name: Silibinin

object_name: rheumatoid arthritis


subject: CHEBI:9144

object_name: psoriasis


subject: CHEBI:9144

object_name: psoriatic arthritis


subject: CHEBI:125451

subject_name: silymarin


subject: CHEBI:125451


subject: CHEBI:125451


subject: MESH:C000620333

object_name: type 2 diabetes mellitus


subject: CHEBI:4953

subject_name: Exemestane

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:4953

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:4953

object_name: Carcinoma breast stage I


subject: CHEBI:4953

object_name: progesterone-receptor positive breast cancer


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Her2-receptor negative breast cancer


subject: CHEBI:93775


subject: CHEBI:93775

object_name: malignant neoplasm of breast stage I


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: UNII:08AN7WA2G0

subject_name: TRIPTORELIN PAMOATE

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:08AN7WA2G0

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:08AN7WA2G0

object_name: Stage IIIA Breast Carcinoma


subject: UNII:08AN7WA2G0


subject: UNII:08AN7WA2G0

object_name: Breast cancer stage II


subject: UNII:08AN7WA2G0

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UNII:08AN7WA2G0

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UNII:08AN7WA2G0

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UNII:08AN7WA2G0

object_name: estrogen-receptor positive breast cancer


subject: UNII:08AN7WA2G0


subject: UNII:08AN7WA2G0


subject: UNII:08AN7WA2G0


subject: UNII:08AN7WA2G0


subject: UNII:08AN7WA2G0


subject: UMLS:C1145204

subject_name: INJECTION, TRIPTORELIN PAMOATE, 3.75 MG ADMINISTERED


subject: UMLS:C1145204


subject: UMLS:C1145204


subject: UMLS:C1145204


subject: UMLS:C1145204


subject: UMLS:C1145204


subject: UMLS:C1145204


subject: UMLS:C1145204


subject: UMLS:C1145204


subject: UMLS:C1145204


subject: UMLS:C1145204


subject: UMLS:C1145204


subject: UMLS:C1145204


subject: UMLS:C1145204


subject: CHEBI:63633

subject_name: Triptorelin


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: UMLS:C0112708

subject_name: Trelstar


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: CHEBI:32296

subject_name: vinorelbine L-tartrate


subject: CHEBI:32296


subject: CHEBI:32296


subject: CHEBI:32296


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: CHEBI:53750

subject_name: vinorelbine D-tartrate


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:45783

subject_name: Imatinib

object_name: Gastrointestinal Stromal Tumor of the Gastrointestinal Tract


subject: CHEBI:45783

object_name: Gastrointestinal stromal cancer


subject: UNII:4MOD1F4ENC

subject_name: Ziftomenib

object_name: Plexosarcoma


subject: UNII:4MOD1F4ENC

object_name: Childhood Gastrointestinal Stromal Tumor


subject: UNII:4MOD1F4ENC


subject: UNII:4MOD1F4ENC


subject: CHEBI:134689

subject_name: Rucaparib

object_name: cervical cancer


subject: CHEBI:134689

object_name: cervical carcinoma


subject: CHEBI:9123

subject_name: Sertraline

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:9123

object_name: COPD, severe early onset


subject: CHEBI:9123

object_name: chronic obstructive pulmonary disease


subject: CHEBI:9123

object_name: interstitial lung disease


subject: CHEBI:6121

subject_name: Ketamine

object_name: Drug Resistant Epilepsy


subject: CHEBI:39112

subject_name: Bosutinib

object_name: glioblastoma


subject: CHEBI:39112

object_name: Childhood Glioblastoma


subject: CHEBI:39112

object_name: adult glioblastoma


subject: UMLS:C0677882

subject_name: DepoCyt

object_name: neoplastic meningitis


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: GTOPDB:13087

subject_name: divozilimab

object_name: multiple sclerosis


subject: CHEMBL.COMPOUND:CHEMBL5314981

subject_name: DIVOZILIMAB


subject: UMLS:C5446731

subject_name: Divozilimab


subject: CHEBI:27547

subject_name: Zeaxanthin

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:27547

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:27547

object_name: Embolism, Tumor


subject: MESH:D001688

subject_name: Biological Products

object_name: Pregnant


subject: MESH:D001688

object_name: Drug Exposure


subject: MESH:D001688

object_name: Neonatal Deformity


subject: MESH:D001688

object_name: Fetal anomaly


subject: UMLS:C0005515

subject_name: Biological Factors


subject: UMLS:C0005515


subject: UMLS:C0005515


subject: UMLS:C0005515


subject: UMLS:C1134558

subject_name: Chinese Herbs


subject: UMLS:C1134558


subject: UMLS:C1134558


subject: UMLS:C1134558


subject: UMLS:C0768182

subject_name: Bexxar

object_name: plasma cell myeloma


subject: CHEBI:32660

subject_name: asparaginase

object_name: lymphoblastic lymphoma


subject: CHEBI:32660

object_name: Adult Lymphoblastic Lymphoma


subject: CHEBI:32660

object_name: Childhood Lymphoblastic Lymphoma


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: fetal growth restriction


subject: UMLS:C0085297

object_name: Sepsis


subject: UMLS:C0085297

object_name: Sepsis, CTCAE


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: UNII:6XC1PAD3KF

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: UNII:6XC1PAD3KF

object_name: Stage IA Breast Cancer AJCC v7


subject: UNII:6XC1PAD3KF

object_name: stage IA breast cancer


subject: UNII:6XC1PAD3KF

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: UNII:6XC1PAD3KF

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: UNII:6XC1PAD3KF

object_name: Stage IB Breast Cancer AJCC v7


subject: UNII:6XC1PAD3KF

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UNII:6XC1PAD3KF

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UNII:6XC1PAD3KF

object_name: Stage IIB Breast Carcinoma


subject: UNII:6XC1PAD3KF

object_name: malignant neoplasm of breast stage IIb


subject: UNII:6XC1PAD3KF

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UNII:6XC1PAD3KF

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UNII:6XC1PAD3KF

object_name: Stage IIA Breast Carcinoma


subject: UNII:6XC1PAD3KF

object_name: estrogen-receptor positive breast cancer


subject: UNII:6XC1PAD3KF

object_name: progesterone-receptor positive breast cancer


subject: UNII:6XC1PAD3KF

object_name: invasive ductal breast carcinoma


subject: CHEBI:46557

subject_name: Zoledronic acid

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:46557

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:46557

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:46557

object_name: stage IA breast cancer


subject: CHEBI:46557

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:46557

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:46557

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:46557

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:46557

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:46557

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:46557

object_name: malignant neoplasm of breast stage IIb


subject: CHEBI:46557

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:46557

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:46557

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:46557

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:46557

object_name: progesterone-receptor positive breast cancer


subject: CHEBI:46557

object_name: invasive ductal breast carcinoma


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: B-cell neoplasm


subject: UMLS:C1832035


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: nicotine dependence


subject: CHEBI:6931

subject_name: Midazolam

object_name: Copeptin


subject: CHEBI:6427

subject_name: Leuprolide

object_name: Malignant neoplasm of female breast


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: kidney failure


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Haemodynamic rebound


subject: CHEBI:149504

object_name: Coronavinae infectious disease


subject: CHEBI:149504

object_name: acute respiratory distress syndrome


subject: CHEBI:149504

object_name: adult acute respiratory distress syndrome


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: UMLS:C2346805

subject_name: Anti-CD45 Monoclonal Antibody AHN-12

object_name: leukemia


subject: UMLS:C2346805

object_name: childhood leukemia


subject: UMLS:C2346805

object_name: Myelodysplasia


subject: UNII:AHI9T7EDX6

subject_name: Pneumovax 23

object_name: pneumonia


subject: UNII:AHI9T7EDX6

object_name: COVID-19-Associated Pneumonia


subject: RXCUI:287523


subject: RXCUI:287523


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Childhood Brain Neoplasm


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: ovarian cancer


subject: CHEBI:39548

object_name: ovarian neoplasm


subject: CHEBI:39548

object_name: ovarian carcinoma


subject: CHEBI:39548

object_name: metastatic prostate carcinoma


subject: CHEBI:39548

object_name: Ovarian cancer stage IV


subject: CHEBI:39548

object_name: Carcinoma breast stage IV


subject: CHEBI:39548

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:39548

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:39548

object_name: Renal cancer metastatic


subject: CHEBI:39548

object_name: Adenocarcinoma of the prostate metastatic


subject: CHEBI:39548

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: gram-negative bacterial infections


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: bronchiolitis obliterans syndrome


subject: CHEBI:32016

object_name: graft versus host disease


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: ankylosing spondylitis


subject: CHEBI:5801

object_name: inflammatory spondylopathy


subject: CHEBI:5801

object_name: spondyloarthropathy


subject: PUBCHEM.COMPOUND:5339

subject_name: Sulfasalazine


subject: PUBCHEM.COMPOUND:5339


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib

object_name: skin neoplasm


subject: PUBCHEM.COMPOUND:51038893

object_name: skin cancer


subject: CHEBI:63637

subject_name: Vemurafenib


subject: CHEBI:63637


subject: PUBCHEM.COMPOUND:57748689


subject: PUBCHEM.COMPOUND:57748689


subject: UNII:7M346920EV


subject: UNII:7M346920EV


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Bowel incontinence


subject: CHEBI:6909

subject_name: Metronidazole


subject: GTOPDB:9310

subject_name: lirilumab

object_name: Refractory acute myeloid leukemia


subject: GTOPDB:9310

object_name: Recurrent Acute Myeloid Leukemia


subject: GTOPDB:9310

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: GTOPDB:9310

object_name: acute biphenotypic leukemia


subject: GTOPDB:9310

object_name: Infant Acute Biphenotypic Leukemia


subject: UNII:S9XDI9W918

subject_name: LIRILUMAB


subject: UNII:S9XDI9W918


subject: UNII:S9XDI9W918


subject: UNII:S9XDI9W918


subject: UNII:S9XDI9W918


subject: UMLS:C3641620


subject: UMLS:C3641620